中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
KNK437(热激蛋白抑制剂I) | N-Formyl-3,4-methylenedioxy-benzylidine-gamma-butyrolactam | 218924-25-5 | C13H11NO4 |
|
KN-92磷酸盐 | KN-92 phosphate | 1135280-28-2 | C24H28ClN2O7PS |
|
KISTRIN来源于红口蝮(马来亚红口蝮)毒液 | (4S)-5-[[(aR,1R,2bR,3aS,6R,6aS,9S,9aS,11bS,12aS,14bR,15S,15aS,21R,21aS,24S,24aS,27S,27aR,30aS,33S,33aS,39S,39aS,42S,42aS,45S,48R,48aS,51S,51aS,54S,57S,57aS,60S,60aS,63R,63aS,66aS,68R,71S,71aS,74S,77aS,80S,80aS,83S,83aS,86S,86aS,89aR,92S,95R,96aS,99aS)-3a,21a,45-tris(4-aminobutyl)-6a-benzyl-24a,33a-bis[(2S)-butan-2-yl]-89a-[(2S)-2-[N-[(2S)-5-carbamimidamido-1-[(2S)-1-[(1S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl]imino-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]imino-1-hydroxypentan-2-yl]-C-hydroxycarbonimidoyl]pyrrolidine-1-carbonyl]-12a,30a,39,42a,66a-pentakis(3-carbamimidamidopropyl)-15,83,99a-tris(2-carboxyethyl)-11b,48a,60,60a,63a,86a-hexakis(carboxymethyl)-1a,1b,4a,7a,7b,8,10a,10b,11,13a,13b,14,16a,17,19a,20,20b,22a,23,25a,26,28a,29,31a,32,40a,41,43a,44,46a,47,49a,50,53,56,58a,59,61a,62,64a,67a,69,69a,72,72a,75a,78a,81,81a,84,84a,87a,93,95a,98a-pentapentacontahydroxy-51,71a-bis[(1R)-1-hydroxyethyl]-86-(2-hydroxy-2-iminoethyl)-24,77a,96a-tris(3-hydroxy-3-iminopropyl)-9a,71,74,80a-tetrakis(hydroxymethyl)-15a,27,54,57,83a-pentamethyl-9,42-bis(2-methylpropyl)-51a-(2-methylsulfanylethyl)-34a,38,52a,75,87-pentaoxo-3,4,4b,5b,16b,17b,65,66,91a,92a,97,98-dodecathia-b,2a,5a,7,8a,8b,9b,10,11a,12b,13,14a,16,17a,19,19b,20a,22,23a,25,26a,28,29a,31,32a,35a,37,40,41a,43,44a,46,47a,49,50a,52,53a,55,58,59a,61,62a,65a,68a,70,70a,73,73a,76,76a,79a,82,82a,85,85a,88,88a,94,94a,97a-hexacontazaundecacyclo[125.41.25.1321,100.1048,68.263,95.033,37.076,80.088,92.0135,139.0153,157.26,202]icosadicta-b(1b),1a(2a),4a(5a),7,7a(8a),7b(8b),9b(10b),10,10a(11a),12b(13b),13,13a(14a),16,16a(17a),19,19a(20a),19b(20b),22,22a(23a),25,25a(26a),28,28a(29a),31,31a(32a),40,40a(41a),43,43a(44a),46,46a(47a),49,49a(50a),52,55,58,58a(59a),61,61a(62a),64a(65a),67a(68a),69,69a(70a),72,72a(73a),75a(76a),78a(79a),81,81a(82a),84,84a(85a),87a(88a),93,94a(95a),97a(98a)-pentapentacontaen-14b-yl]imino]-4-[[(2S)-6-amino-2-[(2-amino-1-hydroxyethylidene)amino]-1-hydroxyhexylidene]amino]-5-hydroxypentanoic acid | —— | C291H458N96O100S13 |
|
KI 8751; N-(2,4-二氟苯基)-N'-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-氟苯基]脲 | Ki 8751 | 228559-41-9 | C24H18F3N3O4 |
|
KGA和GAC抑制剂(CB-839) | CB-839 | 1439399-58-2 | C26H24F3N7O3S |
|
KB-R7943甲磺酰酸盐 | 2-[2-[4-(4-Nitrobenzyloxy)phenyl]ethyl]isothiourea mesylate | 182004-65-5 | C17H21N3O6S2 |
|
KARSTEDT催化剂 | Karstedt catalyst | 81032-58-8 | C16H36O2PtSi4 |
|
K76羧酸 | K 76 Carboxylic acid | 71117-22-1 | C23H30O7 |
|
K-毒毛旋花子甙 | k-Strophanthoside | 33279-57-1 | C42H64O19 |
|
K-RAS(G12C)抑制剂6 | N-{1-[(2,4-Dichlorophenoxy)acetyl]piperidin-4-Yl}-4-Sulfanylbutanamide | 2060530-16-5 | C17H22Cl2N2O3S |
|
JZL184抑制剂 | 4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate | 1101854-58-3 | C27H24N2O9 |
|
JWH073丁酸代谢物 | 4-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]butanoic acid | 1307803-52-6 | C23H19NO3 |
|
JWH0187-羟基吲哚代谢物 | (7-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 1307803-45-7 | C24H23NO2 |
|
JWH-398((4-氯萘-1-基)(1-pentylindol-3-基)甲酮)标准品 | JWH-398 | 1292765-18-4 | C24H22ClNO |
|
JWH-1225-羟基戊基 | JWH-122 N-(5-hydroxypentyl)metabolite | 1379604-68-8 | C25H25NO2 |
|
JWH-018omega-羟基戊基 | JWH-018 N-(5-Hydroxypentyl) | 335161-21-2 | C24H23NO2 |
|
JWH-018N-戊基-5-羧酸 | 5-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]pentanoic acid | 1254475-87-0 | C24H21NO3 |
|
JWH 251 4-甲基苯基异构体 | 2-(4-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone | 864445-41-0 | C22H25NO |
|
JWH 203 3-氯异构体 | JWH 237 | 864445-56-7 | C21H22ClNO |
|
JPM 565 乙基酯 | [125I]-JPM-OEt | 262381-84-0 | C20H28N2O6 |
|
JP1302二盐酸盐 | MMV006172 | 80259-18-3 | C24H24N4 |
|
JNK抑制剂II,阴性对照 | JNK Inhibitor II, Negative Control | 54642-23-8 | C15H10N2O |
|
JNK抑制剂(BI-78D3) | 4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one | 883065-90-5 | C13H9N5O5S2 |
|
JNJ-40346527游离态 | 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide | 1142363-52-7 | C27H35N5O2 |
|
JNJ 5207787; 反式-N-(1-乙酰基-2,3-二氢-1H-吲哚-6-基)-3-(3-氰基苯基)-N-[1-(2-环戊基乙基)哌啶-4-基]丙烯酰胺 | trans-N-(1-acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)piperidin-4-yl]acrylamide | 683746-68-1 | C32H38N4O2 |
|
JNJ 3026582; 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑 | RWJ67657 | 215303-72-3 | C27H24FN3O |
|
JDTic;(3R)-1,2,3,4-四氢-7-羟基-N-[(1S)-1-[[(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基]甲基]-2-甲基丙基]-3-异喹啉甲酰胺 | (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide | 361444-66-8 | C28H39N3O3 |
|
JAK2抑制剂V,Z3 | NSC 42834 | 195371-52-9 | C23H24N2O |
|
I咪达那新杂质(N-(3氨基甲酰基3,3-DIPHENYLPROPYL)-OXAMIC酸) | N-(3-carbamoyl-3,3-diphenylpropyl)oxamic acid | 503598-07-0 | C18H18N2O4 |
|
Ivacaftor苯磺酸盐 | N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide.besylate | 1134822-09-5 | C6H6O3S*C24H28N2O3 |
|
Isoboonein; (4aR,6S,7R,7aS)-六氢-6-羟基-7-甲基环戊并[c]吡喃-3(1H)-酮 | isoboonein | 99946-04-0 | C9H14O3 |
|
Isoboonein acetate; (4aR,6S,7R,7aS)-6-(乙酰氧基)六氢-7-甲基环戊并[c]吡喃-3(1H)-酮 | Isoboonein acetate | 99891-77-7 | C11H16O4 |
|
Isobonducellin; (3Z)-2,3-二氢-7-羟基-3-[(4-甲氧基苯基)亚甲基]-4H-1-苯并吡喃-4-酮 | (Z)-7-hydroxy-3-(4'-methoxybenzylidene)chroman-4-one | 610778-85-3 | C17H14O4 |
|
Ipragliflozin; (1S)-1,5-脱水-1-C-[3-[(1-苯并噻吩-2-基)甲基]-4-氟苯基]-D-葡糖醇 | ipragliflozin | 761423-87-4 | C21H21FO5S |
|
Im-bzl-L-组氨酸甲酯 | N'-benzyl-L-histidine methyl ester | 19817-75-5 | C14H17N3O2 |
|
Idasanutlin(4-((2R,3S,4R,5S)-3-(3-氯-2-氟苯基)-4-(4-氯-2-氟苯基)-4-氰基-5-新戊基吡咯烷-2-甲酰胺)-3-甲氧基苯甲酸;) | idasanutlin | 1229705-06-9 | C31H29Cl2F2N3O4 |
|
IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 | N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide | 686770-61-6 | C22H18N4O2S3 |
|
IU1抑制剂 | 1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(pyrrolidin-1-yl)ethan-1-one | 314245-33-5 | C18H21FN2O |
|
ITI214自由基 | (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one | 1160521-50-5 | C29H26FN7O |
|
IS(+)-3-溴樟脑-10-磺酸 | ((1S,3S,4S)-3-bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate | 206860-46-0 | C10H17BrO5S |
|
IRTK激活剂,负控制 | 3,6-dihydroxy-2-(4-methoxyphenyl)-5-phenyl-1,4-benzoquinone | 6172-50-5 | C19H14O5 |
|
IRE1抑制剂(STF-083010) | N-[(2-hydroxy-1-naphthalenyl)methylene]-2-thiophenesulfonamide | 307543-71-1 | C15H11NO3S2 |
|
IRAK抑制剂5;3-硝基-N-[1-(3-羟基丙基)-5-(2,2-二甲基丙酰基氧基)-1H-苯并咪唑-2-基]苯甲酰胺 | 1-(3-Hydroxypropyl)-2-[(3-Nitrobenzoyl)amino]-1h-Benzimidazol-5-Yl Pivalate | 509093-60-1 | C22H24N4O6 |
|
IRAK-1-4 抑制剂 I | IRAK-1/4 Inhibitor | 509093-47-4 | C20H21N5O4 |
|
IRAK 抑制剂 6; N-[2-甲氧基-4-(4-吗啉基)苯基]-2-(3-吡啶基)-4-噻唑甲酰 | IRAK inhibitor 6 | 1042672-97-8 | C20H20N4O3S |
|
IR-797氯化物 | IR-797 chloride | —— | C31H34ClN2*Cl |
|
IR-780 碘化物 | IR-780 | 207399-07-3 | C36H44ClN2*I |
|
IR-775 氯化物 | IR-775 chloride | 199444-11-6 | C32H36ClN2*Cl |
|
IR-1048四氟硼酸盐 | 1-(2,6-dimethylphenyl)-3-(3-propanol)thiourea | 120077-91-0 | C12H18N2OS |
|
IPI145中间体-5 | 8-chloro-2-phenyl-3-((1S)-1-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one | 1350643-73-0 | C27H25ClN6O2 |
|